An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

1. Durán-Sotuela, A.
2. Vázquez-García, J.
3. Relaño-Fernández, S.
4. Balboa-Barreiro, V.
5. Fernández-Tajes, J.
6. Blanco, F.J.
7. Rego-Pérez, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3389/FPHAR.2024.1426826 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus